The antimalarial drugs chloroquine and primaquine inhibit pyridoxal kinase, an essential enzyme for vitamin B6 production
- 23 August 2014
- journal article
- Published by Wiley in FEBS Letters
- Vol. 588 (20) , 3673-3676
Abstract
Quinoline derivatives such as chloroquine and primaquine are widely used for the treatment of malaria. These drugs are also used for the treatment of trypanosomiasis, and more recently for cancer therapy. However, molecular target(s) of these drugs remain unclear. In this study, we have identified human pyridoxal kinase as a binding protein of primaquine. Primaquine inhibited pyridoxal kinases of malaria, trypanosome and human, while chloroquine inhibited only malaria pyridoxal kinase. Thus, we have identified pyridoxal kinase as a possible target molecule of the antimalarial drugs chloroquine and primaquine.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science, and Technology
This publication has 16 references indexed in Scilit:
- Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responsesOncogene, 2013
- Chloroquine in Cancer Therapy: A Double-Edged Sword of AutophagyCancer Research, 2013
- Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunityImmunological Reviews, 2012
- Chemical, genetic and structural assessment of pyridoxal kinase as a drug target in the African trypanosomeMolecular Microbiology, 2012
- Vitamin B6 salvage enzymes: Mechanism, structure and regulationBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- Primaquine revisited six decades after its discoveryEuropean Journal of Medicinal Chemistry, 2009
- Crystal Structure of human pyridoxal kinase: Structural basis of M+ and M2+ activationProtein Science, 2007
- Analysis of the Vitamin B6 Biosynthesis Pathway in the Human Malaria Parasite Plasmodium falciparumJournal of Biological Chemistry, 2005
- Heme polymerase: Modulation by chloroquine treatment of a rodent malariaLife Sciences, 1992
- Compartmentalization of pyridoxal-5′-phosphate during the acute phase of myocardial infarctionJournal of Molecular Medicine, 1988